American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: http://www.sciepub.com/journal/ajmcr Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
Go
American Journal of Medical Case Reports. 2015, 3(2), 40-41
DOI: 10.12691/ajmcr-3-2-6
Open AccessCase Report

Systemic Lupus Erythematosus Revealing Splenic Marginal Zone Lymphoma. A Case Report

Bel Feki N1, , Smiti Khanfir M1, Said F1, Hamzaoui A1, Ben Salem T1, Ben Ghorbel I1, Lamloum M1, Ben Romdhane N1 and Houman MH1

1Internal Medicine Department. University hospital of La Rabta, Tunis. Tunisia

Pub. Date: January 23, 2015

Cite this paper:
Bel Feki N, Smiti Khanfir M, Said F, Hamzaoui A, Ben Salem T, Ben Ghorbel I, Lamloum M, Ben Romdhane N and Houman MH. Systemic Lupus Erythematosus Revealing Splenic Marginal Zone Lymphoma. A Case Report. American Journal of Medical Case Reports. 2015; 3(2):40-41. doi: 10.12691/ajmcr-3-2-6

Abstract

Autoimmune manifestations are common in splenic marginal zone lymphoma (SMZL) and are sometimes the presenting feature of the disease. We report Herein the case of a 72-year old woman presenting with systemic lupus erythematosus revealing SMZL. To our knowledge, there are only 3 case reports of SLE associated to SMZL. In case of authentic autoimmune disease with unusual clinical features Physician awareness is recommended, to rule out associated lymphoproliferative syndrome.

Keywords:
systemic lupus erythematosus splenic marginal zone lymphoma

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  H. Voinchet, G. Etienne, C.B. Ghiringelli, et al. Splenic marginal zone lymphoma and autoimmunity: Report of six cases. Rev Med Interne 2010; 31: 4-11.
 
[2]  Schmid C, Kirkham N, Diss T, et al. Splenic marginal zone cell lymphoma. Am J Surgical Pathology 1992; 16: 455-66.
 
[3]  Thieblemont C, Felman P, Berger F, et al. Treatment of splenic marginal zone B-cell lymphoma: an analysis of 81 patients. Clin Lymph 2002; 3: 41-7.
 
[4]  Arcaini L, Paulli M, Boveri E, et al. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer 2004; 100: 107-15.
 
[5]  Thieblemont C, Felman P, Callet-Bauchu E, et al. Splenic marginal-zone lymphoma: a distinct clinical and pathological entity. Lancet Oncol 2003; 4: 95-103.
 
[6]  Oscier D, Owen R, Johnson S. Splenic marginal zone lymphoma. Blood Rev 2005; 19:39-51.
 
[7]  Manner H, Jung B, Tonassi L, et al. Successful treatment of catastrophic antiphospholipid antibody syndrome (CAPS) associated with splenic marginal-zone lymphoma with low-molecular-weight heparin, rituximab and bendamustine. Am J Med Sci 2008; 335: 394-7.
 
[8]  Hayem G, Perdu J, Belmatoug N, et al. Syndrome lupique révélant un lymphome B lymphoplasmocytique splénique de la zone marginale. Rev Med Interne 1999; 20: 182-4.
 
[9]  Buskila D, Gladman DD, Hannah W, et al. Primary malignant lymphoma of the spleen in systemic lupus erythematosus. J Rheumatol 1989; 16: 993-6.
 
[10]  Löfström B, Backlin C, Sundström C, et al. A closer look at non-Hodgkin’s lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study. Ann Rheum Dis 2007; 66: 1627-32.